Stockscreener 앱 받기
17.89
2.23%
0.39
시간 외 거래:
17.89
전일 마감가:
$17.50
열려 있는:
$17.875
하루 거래량:
235.34K
Relative Volume:
0.75
시가총액:
$607.56M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.42%
1개월 성능:
+13.44%
6개월 성능:
-40.84%
1년 성능:
+0.00%
1일 변동 폭
$17.75
$18.14
1주일 범위
$16.40
$18.14
52주 변동 폭
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
CBLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
17.89 | 607.56M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
Nuveen Asset Management LLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell CEO Chao Xingjuan sells $425,000 in stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $425,000 in stock - Investing.com
Ameriprise Financial Inc. Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
BNP Paribas Financial Markets Invests $43,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strategic Growth and Profitability Amidst Market Challenges - TipRanks
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys Shares of 6,957 CeriBell (NASDAQ:CBLL) - Defense World
The medtech IPO window is finally open. Or is it? - MedTech Dive
CeriBell (NASDAQ:CBLL) Receives $32.50 Average Price Target from Brokerages - Defense World
Northern Trust Corp Invests $2.66 Million in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strong Q1 Performance and Promising Growth Justify Buy Rating - TipRanks
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Ceribell CEO Chao Xingjuan sells $424,000 in stock - Investing.com Australia
Ceribell CEO Chao Xingjuan sells $424,000 in stock By Investing.com - Investing.com South Africa
Tower Research Capital LLC TRC Takes $37,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
Ceribell stock holds $36 target amid US-China trade deal hopes By Investing.com - Investing.com South Africa
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com Nigeria
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Reports Strong Q1 2025 Growth - TipRanks
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Inc (CBLL) 재무 분석
Ceribell Inc (CBLL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Ceribell Inc 주식 (CBLL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Jun 03 '25 |
Sale |
17.00 |
25,000 |
425,000 |
776,022 |
0.56%
1.70%
자본화:
|
볼륨(24시간):